Yabin Tang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeting AKR1B1 reprograms tumor-associated macrophages to enhance antitumor immunity.
Journal: Journal for immunotherapy of cancer
Published: January 06, 2026
GLUT6-facilitated noncanonical glucose metabolic rewiring enables resistance to targeted cancer therapy.
Journal: Nature communications
Published: May 06, 2025
DAZAP2, regulated by miR-125b, contributes to inflammation-related non-small cell lung cancer progression.
Journal: Translational oncology
Published: December 16, 2024
Therapeutic targeting de novo purine biosynthesis driven by β-catenin-dependent PPAT upregulation in hepatoblastoma.
Journal: Cell death & disease
Published: September 06, 2024
Simultaneous determination of canonical purine metabolism using a newly developed HILIC-MS/MS in cultured cells.
Journal: Journal of pharmaceutical and biomedical analysis
Published: June 30, 2024
Folylpolyglutamate synthetase inactivation in relapsed ALL induces a druggable folate metabolic vulnerability.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: March 05, 2024
Metabolomics analysis reveals Oct4 overexpression drives metabolic reprogramming and enhanced glycolysis and pentose phosphate pathway in lung adenocarcinoma cells.
Journal: Biomedical chromatography : BMC
Published: November 09, 2021
The KRAS-G12D mutation induces metabolic vulnerability in B-cell acute lymphoblastic leukemia.
Journal: iScience
Published: June 30, 2021
Determination of Meserine, a new candidate for Alzheimer's disease in mice brain by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic and tissue distribution study.
Journal: Analytical and bioanalytical chemistry
Published: January 21, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026